ConductScience.org, home

Paper39100682

Mismatch repair-proficient tumor footprints in the sands of immune desert: mechanistic constraints and precision platforms.

Majumder B and 3 others. Front Immunol, 2024. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Mismatch repair-proficient tumor footprints in the sands of immune desert: mechanistic constraints and precision platforms. Papers, record 39100682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39100682

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mismatch repair-proficient tumor footprints in the sands of immune desert: mechanistic constraints and precision platforms.
PubMed
Journal
Front Immunol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.61, provisional
iCite
Revised in PubMed
2026-08-31
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Majumder BBiswanath
2Nataraj NBNishanth Belugali
3Maitreyi LLeela
4Datta SSantanu

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Tumor MicroenvironmentMajor topic
DNA Mismatch RepairMajor topic
Humans
Precision Medicine
Animals
Colorectal Neoplasms
Signal Transduction

Source PubMed

Download CSV of topics

References235

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138495713Assessing cell viability with dynamic optical coherence microscopy.Biomed Opt Express2024https://conductscience.org/library/papers/38495713PubMed
228187290Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.Cell2017https://conductscience.org/library/papers/28187290PubMed
334581895Live cell molecular analysis of primary prostate cancer organoids identifies persistent androgen receptor signaling.Med Oncol2021https://conductscience.org/library/papers/34581895PubMed
419909745Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer.Gastroenterology2010https://conductscience.org/library/papers/19909745PubMed
534343496CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment.Cell2021https://conductscience.org/library/papers/34343496PubMed
633828294Evaluating eligibility criteria of oncology trials using real-world data and AI.Nature2021https://conductscience.org/library/papers/33828294PubMed
735687697ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer.Sci Immunol2022https://conductscience.org/library/papers/35687697PubMed
835508177Patient-derived micro-organospheres enable clinical precision oncology.Cell Stem Cell2022https://conductscience.org/library/papers/35508177PubMed
931730395The Acidic Tumor Microenvironment as a Driver of Cancer.Annu Rev Physiol2020https://conductscience.org/library/papers/31730395PubMed
1036509911Rational combinations of targeted cancer therapies: background, advances and challenges.Nat Rev Drug Discov2023https://conductscience.org/library/papers/36509911PubMed
1132451418TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer.Nat Commun2020https://conductscience.org/library/papers/32451418PubMed
1235145327Ex vivo organotypic cultures for synergistic therapy prioritization identify patient-specific responses to combined MEK and Src inhibition in colorectal cancer.Nat Cancer2022https://conductscience.org/library/papers/35145327PubMed
1325554788Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions.Science2015https://conductscience.org/library/papers/25554788PubMed
1435247870Artificial intelligence for detection of microsatellite instability in colorectal cancer-a multicentric analysis of a pre-screening tool for clinical application.ESMO Open2022https://conductscience.org/library/papers/35247870PubMed
1533554860shinyDepMap, a tool to identify targetable cancer genes and their functional connections from Cancer Dependency Map data.Elife2021https://conductscience.org/library/papers/33554860PubMed
1638266104The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers.Sci Transl Med2024https://conductscience.org/library/papers/38266104PubMed
1736596344Discordance of microsatellite instability and mismatch repair immunochemistry occurs depending on the cancer type.Hum Pathol2023https://conductscience.org/library/papers/36596344PubMed
1838039966Intestinal microbiota-specific Th17 cells possess regulatory properties and suppress effector T cells via c-MAF and IL-10.Immunity2023https://conductscience.org/library/papers/38039966PubMed
1933051339Role of myeloid-derived suppressor cells in the promotion and immunotherapy of colitis-associated cancer.J Immunother Cancer2020https://conductscience.org/library/papers/33051339PubMed
2037074042BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth.Cancer Res2023https://conductscience.org/library/papers/37074042PubMed

See all 235 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42781243Targeting the DNA Damage Response in Cancer.MedComm (2020)2026https://conductscience.org/library/papers/42781243PubMed
42596654cGAS-STING pathway activation drives the cold-to-hot tumor transition and sensitizes immunotherapy.Cancer Biol Med2026https://conductscience.org/library/papers/42596654PubMed
42459668Immune checkpoint inhibitors in dMMR-MSI-H colorectal cancer: rationale, progress and prospects.Front Immunol2026https://conductscience.org/library/papers/42459668PubMed
42369139Relationship between MLH1, MSH2, MSH6, and PMS2 protein expression status and clinicopathological characteristics in colorectal cancer tissues.Front Med (Lausanne)2026https://conductscience.org/library/papers/42369139PubMed
41583489Adenosine receptors on the immuno-oncology expressway: TIME, perspectives, and translation.Front Immunol2025https://conductscience.org/library/papers/41583489PubMed
41080580Metformin-associated gut microbiota remodeling correlates with reinvigorated splenic immunity in aged mice: microbiome-immune crosstalk via the gut-spleen axis.Front Immunol2025https://conductscience.org/library/papers/41080580PubMed
40453103Enhancing detection and monitoring of circulating tumor cells: Integrative approaches in liquid biopsy advances.J Liq Biopsy2025https://conductscience.org/library/papers/40453103PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39100682

GET https://conductscience.org/api/papers/v1/39100682/references?page=2